Complement system and age-related macular degeneration: drugs and challenges

Area of Science:

• Ophthalmology
• Immunology
• Pharmacology

Background:

• Age-related macular degeneration (AMD) is a leading cause of vision loss globally.
• AMD is a complex disease with multiple contributing factors.
• The complement system, a part of the immune system, is increasingly implicated in AMD pathogenesis.

Purpose of the Study:

• To review the role of complement pathways in age-related macular degeneration.
• To discuss current therapeutic strategies targeting the complement system in AMD.
• To provide an overview of existing and developing treatments for AMD.

Main Methods:

• Literature review of scientific publications and clinical trial data.
• Analysis of complement pathways implicated in AMD.
• Synthesis of information on current and investigational AMD therapies.

Main Results:

• The complement system plays a significant role in the development and progression of AMD.
• Various therapeutic approaches targeting complement pathways are under investigation.
• Several drugs targeting complement are currently in clinical trials for AMD treatment.

Conclusions:

• Targeting the complement system represents a promising therapeutic avenue for AMD.
• Continued research and clinical trials are essential for developing effective AMD treatments.
• Understanding complement's role is crucial for advancing AMD patient care.